Vanguard Global Advisers
ROIV icon

Vanguard Global Advisers’s Roivant Sciences ROIV Stock Holding History

Vanguard Global Advisers’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.92M Sell
195,443
-12,265
-6% -$362K ﹤0.01% 701
2026
Q1 		$5.75M Buy
+207,708
New +$5.34M ﹤0.01% 720

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Global Advisers's ROIV Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Roivant Sciences (ROIV) stake by 5.9% in Q2 2026, selling an estimated $362K and leaving 195,443 shares worth $6.92M. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Vanguard Global Advisers first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 490 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Vanguard Global Advisers held 195,443 shares of Roivant Sciences worth $6.92M as of Q2 2026.
  • Vanguard Global Advisers sold 12,265 Roivant Sciences shares in Q2 2026, an estimated $362K.
  • Roivant Sciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #701 holding.
  • Vanguard Global Advisers first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • 490 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.